BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
PDX1
,
Angiogenesis
,
HIV infection
,
Pancreas
,
Amniocentesis
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DARPP 32
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Huntington's disease phenotypes in induced pluripotent stem cells
Dopamine Signaling in Parkinson disease model
Gene expression profiles of Herceptin-resistant breast cancer cells
Explore Curated Studies Results
Literature
Most Relevant Literature
The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: a novel therape…
Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of d…
Localization of dopamine- and cAMP-regulated phosphoprotein-32 and inhibitor-1 in area 9 of Macaca m…
Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tum…
T2 and T2* magnetic resonance imaging sequences predict brain injury after intracerebral hemorrhage …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pilot Study Evaluating Neuro-Imaging Correlates of Epigenetic Finding in Prediction of Chronic Posts…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ